Bloomberg Pfizer Inc has agreed to buy Global Blood Therapeutics Inc, the maker of a drug for sickle-cell disease, in a deal worth $5.4 billion. The New York drug giant will pay $68.50 for all outstanding shares of Global Blood, the companies said in a statement before US markets opened. That’s double the price of the stock on August ...

  Bloomberg Veolia Environnement SA agreed to sell Suez SA’s waste activities in Britain to Macquarie Group Ltd. for 2.4 billion euros ($2.44 billion) after the country’s antitrust authority raised competition concerns. Veolia’s announcement, confirming an earlier Bloomberg News report, marks the last step in its acquisition of a large chunk of French rival Suez, which was completed in other ...

  Bloomberg Hungarian inflation accelerated to the fastest in 24 years, offering no reprieve for a central bank that’s raised interest rates by most in the EU. Consumer prices rose 13.7% in July from a year earlier, exceeding all estimates in a Bloomberg survey. Core inflation, which strips out volatile commodity prices, was even higher at 16.7%, pointing to broad-based ...